CNBC's Meg Tirrell hones in on volatility in biotech IPOs and analyzes 2015's IPO returns and the investor base in biotech stocks.
Get the best of CNBC in your inbox
Dan Mangan is a reporter covering health care for CNBC.com.
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.